Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage

Details for Australian Patent Application No. 2007309479 (hide)

Owner The Brigham and Women's Hospital, Inc.

Inventors Lee, Richard; Segers, Vincent

Agent Pizzeys

Pub. Number AU-A-2007309479

PCT Pub. Number WO2008/051505

Priority 60/853,441 23.10.06 US; 11/976,032 19.10.07 US; 60/929,353 22.06.07 US

Filing date 22 October 2007

Wipo publication date 2 May 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 9/50 (2006.01) Enzymes, e.g. ligases (6.) - Proteinases

Event Publications

14 May 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 Apr 2009

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/051505 Priority application(s): WO2008/051505

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007309488-HCV NS3 protease inhibitors

2007309478-RFID collar